BACKGROUND: Observational data can be useful for drug safety research, but accurate measurement of adverse health outcomes is paramount. Best practices for identifying important health outcomes of interest (HOI) are needed. OBJECTIVES: To evaluate the extent to which health outcome definitions commonly used in observational database studies identify cases that are consistent with expert panel assessment of the underlying data. METHODS: Competing HOI definitions were used to identify potential cases of acute liver injury (ALI; n = 208), acute kidney injury (AKI; n = 200), and myocardial infarction (MI; n = 204) in the Truven MarketScan Lab Database (MSLR). Panelists reviewed patient-level data and answered questions about whether they believed the case actually reflected the HOI and their certainty of case classification on a 10-point scale (1 = unlikely to 10 = likely). Each patient was reviewed independently by two panelists. Case disagreements were resolved through consensus meetings. Positive predictive value (PPV) was calculated as the number of cases deemed to be true over the total number of sampled cases. Kappa statistics assessed inter-rater agreement. RESULTS: PPV ranged from 0 to 52 % across ALI definitions, 12 to 82 % across AKI definitions, and 1 to 56 % across MI definitions. Certainty scores on the 10-point scale paralleled the PPV, with a range of mean values from 1.7 to 4.8 across ALI definitions, 3.1 to 6.0 across AKI definitions, and 2.8 to 5.7 across MI definitions. Inter-rater agreement was low to moderate (Kappa range 0.0-0.6). IMPLICATIONS/ CONCLUSIONS: Existing HOI definitions had relatively low PPV based on expert panel review. Experts commonly disagreed on case classification. Additional work is needed to refine HOI case definitions if observational data are to be reliably used for health outcome assessment.
BACKGROUND: Observational data can be useful for drug safety research, but accurate measurement of adverse health outcomes is paramount. Best practices for identifying important health outcomes of interest (HOI) are needed. OBJECTIVES: To evaluate the extent to which health outcome definitions commonly used in observational database studies identify cases that are consistent with expert panel assessment of the underlying data. METHODS: Competing HOI definitions were used to identify potential cases of acute liver injury (ALI; n = 208), acute kidney injury (AKI; n = 200), and myocardial infarction (MI; n = 204) in the Truven MarketScan Lab Database (MSLR). Panelists reviewed patient-level data and answered questions about whether they believed the case actually reflected the HOI and their certainty of case classification on a 10-point scale (1 = unlikely to 10 = likely). Each patient was reviewed independently by two panelists. Case disagreements were resolved through consensus meetings. Positive predictive value (PPV) was calculated as the number of cases deemed to be true over the total number of sampled cases. Kappa statistics assessed inter-rater agreement. RESULTS: PPV ranged from 0 to 52 % across ALI definitions, 12 to 82 % across AKI definitions, and 1 to 56 % across MI definitions. Certainty scores on the 10-point scale paralleled the PPV, with a range of mean values from 1.7 to 4.8 across ALI definitions, 3.1 to 6.0 across AKI definitions, and 2.8 to 5.7 across MI definitions. Inter-rater agreement was low to moderate (Kappa range 0.0-0.6). IMPLICATIONS/ CONCLUSIONS: Existing HOI definitions had relatively low PPV based on expert panel review. Experts commonly disagreed on case classification. Additional work is needed to refine HOI case definitions if observational data are to be reliably used for health outcome assessment.
Authors: J Marc Overhage; Patrick B Ryan; Christian G Reich; Abraham G Hartzema; Paul E Stang Journal: J Am Med Inform Assoc Date: 2011-10-28 Impact factor: 4.497
Authors: Paul E Stang; Patrick B Ryan; Judith A Racoosin; J Marc Overhage; Abraham G Hartzema; Christian Reich; Emily Welebob; Thomas Scarnecchia; Janet Woodcock Journal: Ann Intern Med Date: 2010-11-02 Impact factor: 25.391
Authors: Meghan E O Vlasschaert; Shayna A D Bejaimal; Daniel G Hackam; Robert Quinn; Meaghan S Cuerden; Matthew J Oliver; Arthur Iansavichus; Nabil Sultan; Alison Mills; Amit X Garg Journal: Am J Kidney Dis Date: 2011-01 Impact factor: 8.860
Authors: Brent I Fox; Joshua C Hollingsworth; Michael D Gray; Michael L Hollingsworth; Juan Gao; Richard A Hansen Journal: J Biomed Inform Date: 2013-06-13 Impact factor: 6.317
Authors: Patrick B Ryan; Martijn J Schuemie; Emily Welebob; Jon Duke; Sarah Valentine; Abraham G Hartzema Journal: Drug Saf Date: 2013-10 Impact factor: 5.606
Authors: Rosa Gini; Martijn Schuemie; Jeffrey Brown; Patrick Ryan; Edoardo Vacchi; Massimo Coppola; Walter Cazzola; Preciosa Coloma; Roberto Berni; Gayo Diallo; José Luis Oliveira; Paul Avillach; Gianluca Trifirò; Peter Rijnbeek; Mariadonata Bellentani; Johan van Der Lei; Niek Klazinga; Miriam Sturkenboom Journal: EGEMS (Wash DC) Date: 2016-02-08